Ramya, P. et al. 2024. Development of a Validated RP-HPLC/UV Method for the Quantitative Determination of Tyrosine Kinase RET Inhibitor: Selpercatinib in Capsule Formulation. Journal of Drug Delivery and Therapeutics. 14, 7 (Jul. 2024), 57–63. DOI:https://doi.org/10.22270/jddt.v14i7.6702.